Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical trials and biomarker research on lung cancer in China.

Expert opinion on therapeutic targets - 1 Mar 2012

Wu Yi-long, Zhou Qing

Abstract excerpt

INTRODUCTION: Over the past 10 years, there have been significant advances in clinical trials and translation research on lung cancer in China. These advances have changed the clinical practice of lung cancer treatment. Translation research has clarified many molecular mechanisms of lung cancer development, growth and metastasis. Based on these results, a few cancer-driving molecular targets were identified. Many...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Clinical Trials as Topic
Share to Cytochrome P-450 CYP1A1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ErbB Receptors

Share to Gefitinib

Share to Protein Kinase Inhibitors

Share to Quinazolines

Share to Translational Research, Biomedical

Source

Identifiers

PMID: 22313283
DOI: 10.1517/14728222.2011.630663

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical trials and biomarker research on lung cancer in China.PMID 22313283Read ↗

Novel targeted agents for the treatment of lung cancer in China.Semantic proximity Read ↗

Lung cancer and metastasis: new opportunities and challenges.Semantic proximity Read ↗

Differences between lung adenocarcinoma and lung squamous cell carcinoma: Driver genes, therapeutic targets, and clinical efficacySemantic proximity Read ↗

Clinical testing for molecular targets for personalized treatment in lung cancer.Semantic proximity Read ↗

Personalized targeted therapy for lung cancer.Semantic proximity Read ↗

State-of-the-Art Molecular Oncology of Lung Cancer in Taiwan.Semantic proximity Read ↗

[Current Status and Future Perspectives of Molecular Targeted Therapies for Lung Cancer].Semantic proximity Read ↗

Catalog of Lung Cancer Gene Mutations Among Chinese PatientsSemantic proximity Read ↗

[Chinese Expert Consensus on Second-line Treatment for Non-small Cell Lung Cancer with Negative Driver Gene Mutations].Semantic proximity Read ↗

[Clinical research and drug review of epidermal growth factor receptor tyrosine kinase inhibitors in advanced non-small cell lung cancer].Semantic proximity Read ↗

Current Landscape of Targeted Therapy in Lung Cancer.Semantic proximity Read ↗

Lung Cancer Genomics in the Era of Accelerated Targeted Drug Development.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.